Insights into tumor vascularization using magnetic resonance imaging and spectroscopy

Experimental Oncology

Volumn 22, Issue 1-2, 2000, Pages 3-7

  Bhujwalla, Z M ^a   Artemov, D ^a   Solaiyappan, M ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Nuclear magnetic resonance; Tumor vascularization

Indexed keywords

EID: 0003535470     PISSN: 02043564     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (34)

1. Jain RK. Transport of molecules across tumor vasculature. Cancer Mestastasis Rev 1987; 6: 559-93.
2. Jain RK. Transport of molecules in the tumor interstitium: a review. Cancer Res 1987; 47: 3039-51.
3. Jain RK. Determinants of tumor blood flow: a review. Cancer Res 1988; 48: 2641-58.
4. Alper T, Howard-Flanders P. Role of oxygen in modifying the radiosensitivity of E. coli B. Nature 1956; 178: 978-9.
5. Thomlinson RH, Gray LH. The histological structure of some human lung cancers and the possible implications for radiotherapy. Brit J Cancer 1955; 9: 539-49.
6. Folkman J. Anti-angiogenesis: new concept for therapy of solid tumors. Ann Surgery 1972: 409-16.
7. Folkman J. How is blood vessel growth regulated in normal and neoplastic tissue ? Cancer Res 1986; 46: 467-73.
8. Folkman J, Watson K, Ingber D, Hanahan D. Induction of angiogenesis during the transition from hyperplasia to neoplasia. Nature 1989; 339: 58-61.
9. Moses MA. The role of vascularization in tumor metastasis. In: William F, Orr Buchanan MR, Weiss L, eds. Microcirculation in Cancer Metastasis CRC Press, 1991: 257-76.
10. Vaupel P, Kallinowski F, Okunieff P. Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review. Cancer Res 1989; 49: 6449-65.
11. Neufeld G, Cohen T, Gengrinovitch S, Poltorak Z. Vascular endothelial growth factor (VEGF) and its receptors. FASEB J 1999; 13: 9-22.
12. Gospodarowicz D, Abraham JA, Schilling J. Isolation and characterization of a vascular endothelial cell mitogen produced by pituitary-derived folliculo stellate cells. Proc Natl Acad Sci USA 1989; 86: 7311-5.
13. Ferrara N, Henzel WJ. Pituitary follicular cells secrete a novel heparin-ninding growth factor specific for vascular endothelial cells. Biochem Biophys Res Commun 1989; 161: 851-8.
14. Senger DR, Galli SJ, Dvorak AM, Perruzzi CA, Harvey VS, Dvorak HF. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science 1983; 219: 983-5.
15. Levy AP, Levy NS, Wegner S, Goldberg MA. Transcriptional regulation of the rat endothelial growth factor gene by hypoxia. J Biol Chem 1995; 270: 13333-40.
16. Claffey KP, Shih SC, Mullen A, Dziennis S, Cuisick JL, Abrams KR, Lee SW, Detmar M. Identification of a human VPF/VEGF 3′ untranslated region mediating hypoxia-induced mRNA stability. Mol Biol Cell 1998; 9: 469-81.
17. Chiarugi V, Magnelli L, Gallo O. Cox-2, iNOS and p53 as play-makers of tumor angiogenesis (Review). Int J Mol Med 1998; 2: 715-9.
18. Brooks SE, Gu X, Kaufmann PM, Marcus DM, Caldwell RB. Modulation of VEGF production by pH and glucose in retinal Muller cells. Curr Eye Res 1998; 17: 875-82.
19. Shweiki D, Neeman M, Itin A, Keshet E. Induction of vascular endothelial growth factor expression by hypoxia and by glucose deficiency in multicell spheroids: Implication for tumor angiogenesis. Proc Natl Acad Sci USA 1995; 92: 768-72.
20. Feldkamp MM, Lau N, Rak J, Kerbel RS, Guha A. Normoxic and hypoxic regulation of vascular endothelial growth factor (VEGF) by astrocytoma cells is mediated by Ras. Int J Cancer 1999; 81: 118-24.
21. Mukhopadhyay D, Tsiokas I, Sukhatme VP. Wild-type p53 and v-src exert opposing influences on human vascular endothelial growth factor gene expression. Cancer Res 1995; 55: 6161-5.
22. Bouvet M, Ellis LM, Nishizaki M, Fujiwara T, Liu W, Bucana CD, Fang B, Lee JJ, Roth JA. Adenovirus-mediated wild type p53 gene transfer down-regulates vascular endothelial growth factor expression and inhibits angiogenesis in human colon cancer. Cancer Res 1998; 58: 2288-92.
23. Agani F, Kirsch DG, Friedman SL, Kastan MB, Semenza GL. p53 does not repress hypoxia-induced transcription of the vascular endothelial growth factor gene. Cancer Res 1997; 57: 4474-7.
24. Abramovitch R, Frenkiel D, Neeman M. Analysis of subcutaneous angiogenesis by gradient echo magnetic resonance imaging. Magn Reson Med 1998; 39: 813-24.
25. Bhujwalla ZM, Artemov D, Glockner J. Tumor angiogenesis, vascularization and contrast enhanced MRI. Topics Magnetic Resonance Imaging 1999; 10: 92-103.
26. Schmiedl U, Ogan M, Paajanen H, Marotti M, Crooks L, Brito AC, Brasch RC. Albumin labeled with Gd-DTPA as an intravascular, blood pool-enhancing agent for MR imaging: biodistribution and imaging studies. Radiology 1987; 162: 205-10.
27. Schwarzbauer C, Syha J, Haase A. Quantification of regional blood volume by rapid T1 mapping. Magnetic Resonance in Medicine 1993; 29: 709-12.
28. Bhujwalla ZM, Artemov D, Solaiyappan M, Mao D, Backer JP. Comparison of vascular volume and permeability for tumors derived from metastatic human breast cancer cells with and without the metastasis suppressor gene nm23. In: Proc 7th Scientific Meeting ISM-RM. Philadelphia, 1999.
29. Artemov D, Bhujwalla ZM. 3-Dimensional MRI quantitation of tumor vascular volume and permeability. In: Proc Scientific Meeting ISMRM. Vancouver, 1997.
30. 15O perfusion measurements in the RIF1 murine tumor in vivo. Radiat Res 1986; 106: 122-31.
31. Terpstra M, High WB, Merkle H, Garwood M. Relationships among lactate concentration, blood flow and histopathologic profiles in rat C6 glioma. NMR in Biomed. 1996; 9: 185-94.
32. Bhujwalla ZM, Artemov D, Solaiyappan M. Vascular Characterization of human breast and prostate cancer models. In: Proc 8th Annual Meeting Intern Society Magnetic Resonance in Medicine. Denver, 2000.
33. 1H NMR spectroscopy. Magnetic Resonance in Medicine 1994; 32: 277-84.
34. 1H MRSI. Mag Res Med 1999; 41: 743-50.